{"id":50225,"date":"2025-01-10T22:54:37","date_gmt":"2025-01-10T22:54:37","guid":{"rendered":"https:\/\/ibima.eu\/?p=50225"},"modified":"2025-01-10T22:54:37","modified_gmt":"2025-01-10T22:54:37","slug":"association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/","title":{"rendered":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_"},"content":{"rendered":"<p>Javier Oliver,\u00a0Juan Luis Onieva,\u00a0Maria Garrido-Barros,\u00a0Alicia Garrido-Aranda,\u00a0Vanessa De Luque,\u00a0Martina Alvarez,\u00a0Alfonso Sanchez,\u00a0Elisabeth Perez,\u00a0Patricia Chaves,\u00a0Maria Jose Lozano,\u00a0Miguel Berciano,\u00a0Manolo Cobo,\u00a0Emilio Alba,\u00a0Antonio Rueda,\u00a0Isabel Barragan &#8211; 2022 &#8211; 10.1158\/1538-7445.am2022-1538<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Javier Oliver,\u00a0Juan Luis Onieva,\u00a0Maria Garrido-Barros,\u00a0Alicia Garrido-Aranda,\u00a0Vanessa De Luque,\u00a0Martina Alvarez,\u00a0Alfonso Sanchez,\u00a0Elisabeth Perez,\u00a0Patricia Chaves,\u00a0Maria Jose Lozano,\u00a0Miguel Berciano,\u00a0Manolo Cobo,\u00a0Emilio Alba,\u00a0Antonio Rueda,\u00a0Isabel Barragan &#8211; 2022 &#8211; 10.1158\/1538-7445.am2022-1538<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1568],"tags":[],"class_list":["post-50225","post","type-post","status-publish","format-standard","hentry","category-publicaciones-b-05"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima\" \/>\n<meta property=\"og:description\" content=\"Javier Oliver,\u00a0Juan Luis Onieva,\u00a0Maria Garrido-Barros,\u00a0Alicia Garrido-Aranda,\u00a0Vanessa De Luque,\u00a0Martina Alvarez,\u00a0Alfonso Sanchez,\u00a0Elisabeth Perez,\u00a0Patricia Chaves,\u00a0Maria Jose Lozano,\u00a0Miguel Berciano,\u00a0Manolo Cobo,\u00a0Emilio Alba,\u00a0Antonio Rueda,\u00a0Isabel Barragan &#8211; 2022 &#8211; 10.1158\/1538-7445.am2022-1538\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-10T22:54:37+00:00\" \/>\n<meta name=\"author\" content=\"Divulgaci\u00f3n\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divulgaci\u00f3n\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/\"},\"author\":{\"name\":\"Divulgaci\u00f3n\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\"},\"headline\":\"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_\",\"datePublished\":\"2025-01-10T22:54:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/\"},\"wordCount\":51,\"commentCount\":0,\"articleSection\":[\"Publicaciones - B-05\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/\",\"name\":\"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-01-10T22:54:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\",\"name\":\"Divulgaci\u00f3n\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"caption\":\"Divulgaci\u00f3n\"},\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/divulgacioncientifica\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/","og_locale":"es_ES","og_type":"article","og_title":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima","og_description":"Javier Oliver,\u00a0Juan Luis Onieva,\u00a0Maria Garrido-Barros,\u00a0Alicia Garrido-Aranda,\u00a0Vanessa De Luque,\u00a0Martina Alvarez,\u00a0Alfonso Sanchez,\u00a0Elisabeth Perez,\u00a0Patricia Chaves,\u00a0Maria Jose Lozano,\u00a0Miguel Berciano,\u00a0Manolo Cobo,\u00a0Emilio Alba,\u00a0Antonio Rueda,\u00a0Isabel Barragan &#8211; 2022 &#8211; 10.1158\/1538-7445.am2022-1538","og_url":"https:\/\/ibima.eu\/es\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/","og_site_name":"Ibima","article_published_time":"2025-01-10T22:54:37+00:00","author":"Divulgaci\u00f3n","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Divulgaci\u00f3n"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/"},"author":{"name":"Divulgaci\u00f3n","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5"},"headline":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_","datePublished":"2025-01-10T22:54:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/"},"wordCount":51,"commentCount":0,"articleSection":["Publicaciones - B-05"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/","url":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/","name":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_ - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-01-10T22:54:37+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/association-of-cerna-dysregulation-with-clinical-response-to-immunotherapy-in-cutaneous-melanoma-cm_\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Association of ceRNA dysregulation with clinical Response to Immunotherapy in cutaneous melanoma (CM)_"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5","name":"Divulgaci\u00f3n","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","caption":"Divulgaci\u00f3n"},"url":"https:\/\/ibima.eu\/es\/author\/divulgacioncientifica\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/50225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=50225"}],"version-history":[{"count":1,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/50225\/revisions"}],"predecessor-version":[{"id":50226,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/50225\/revisions\/50226"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=50225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=50225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=50225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}